Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
8,17 USD | -1,45% | -5,22% | +3,68% |
27/03 | Outlook Therapeutics-aandelen stijgen na BTIG-upgrade | MT |
27/03 | OUTLOOK THERAPEUTICS, INC. : BTIG verhoogt advies naar kopen | ZM |
Omzet 2024 * | 204K 191K | Omzet 2025 * | 11,85 mln. 11,13 mln. | Marktkapitalisatie | 185 mln. 174 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -72 mln. -67,59 mln. | Nettowinst (verlies) 2025 * | -62 mln. -58,2 mln. | EV/omzet 2024 * | 907 x |
Nettoliquiditeiten 2024 * | - 0 | Nettoliquiditeiten 2025 * | - 0 | EV/omzet 2025 * | 15,6 x |
K/w-verhouding 2024 * |
-2,48
x | K/w-verhouding 2025 * |
-3,56
x | Werknemers | 24 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 64,36% |
Recentste transcriptie over Outlook Therapeutics, Inc.
1 dag | -1,45% | ||
1 week | -6,09% | ||
Lopende maand | -31,57% | ||
1 maand | +10,33% | ||
3 maanden | +17,05% | ||
6 maanden | -38,11% | ||
Lopend jaar | +3,68% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
C. Trenary
CEO | Chief Executive Officer | 66 | 07-07-21 |
Lawrence Kenyon
DFI | Director of Finance/CFO | 58 | 15-09-15 |
Surendra Sharma
CTO | Chief Tech/Sci/R&D Officer | - | 19-01-23 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Randy Thurman
CHM | Chairman | 74 | 13-04-18 |
Kurt Hilzinger
BRD | Director/Board Member | 63 | 11-12-15 |
C. Trenary
CEO | Chief Executive Officer | 66 | 07-07-21 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.00% | 9 M€ | +4,23% | - | |
0.00% | 147 M€ | +4,13% | - | |
0.00% | 18 M€ | +2,79% | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
18-04-24 | 8,29 | -3,72% | 234 621 |
17-04-24 | 8,61 | -1,60% | 418 152 |
16-04-24 | 8,75 | +1,51% | 136 801 |
15-04-24 | 8,62 | -0,92% | 234 921 |
12-04-24 | 8,7 | -3,76% | 267 111 |
uitgestelde koers Nasdaq, 19 april 2024 om 22:00 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+3,68% | 185 mln. | |
-1,42% | 41,35 mld. | |
+42,15% | 40,38 mld. | |
+1,97% | 39,05 mld. | |
-14,19% | 26,67 mld. | |
+1,82% | 24,07 mld. | |
-24,55% | 18,36 mld. | |
-4,07% | 11,68 mld. | |
+21,36% | 11,6 mld. | |
+8,20% | 11,15 mld. |